General Updates | The standard of care in multiple myeloma & emerging treatment options
Denis O’Keeffe
• 8 Nov 2022
Denis O’Keeffe, MD, University Hospital Limerick, Limerick, Ireland, outlines current and emerging treatment options for multiple myeloma. Dr O’Keeffe explains that quadruplet-based induction therapy combined with autologous transplantation is likely to become the standard of care (SOC) in young and fit patients. In addition, Dr O’Keeffe also shares his excitement for upcoming data on novel bispecific antibodies and CAR-T therapies. This interview was recorded virtually.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
